Newsbenzinga
Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio
· Published
Article summary
Biogen beat second-quarter earnings and revenue estimates, raised its 2026 guidance, and reported pipeline progress.
An excerpt from the original article.
Comments —
Loading comments…